Latest Quinolone Stories
DALLAS, January 8, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Partnering Terms and Agreements reports for Personalized Medicine and Antibiotics industries to the pharmaceuticals
Drug Pricing Will be Key Factor in Hospital Formulary Uptake of Novel Gram-Negative Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept.
LONDON, Sept. 22, 2014 /PRNewswire/ -- About AntibioticsAntibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria.
Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc.
Transparency Market Research published a new report "Antibacterial Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
New research study “Antibiotics Partnering Terms and Agreements” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB)
DUBLIN, June 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/l2jzql/antibacterial)
FAIRFIELD, N.J., June 12, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that its licensor, Ferrer, has initiated the second Phase III clinical study for Ozenoxacin,
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.